カテゴリ： 世界, 医療/バイオ, Market Monitor Global

アルパース病治療のグローバル市場展望 2023年-2029年：言語療法、理学療法、その他

■ 英語タイトル：Alpers Disease Treatment Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12239）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12239
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アルパース病治療のグローバル市場展望 2023年-2029年：言語療法、理学療法、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のアルパース病治療市場規模と予測を収録しています。・世界のアルパース病治療市場：売上、2018年-2023年、2024年-2029年
・世界のアルパース病治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のアルパース病治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「言語療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

アルパース病治療のグローバル主要企業は、Roche Holdings AG、 Pfizer Inc.、 Novartis International AG、 Sanofi S.A.、 Merck & Co.Inc.、 Biogen Inc.、 Moderna Inc.、 Vertex Pharmaceuticals Incorporated、 Alexion Pharmaceuticals Inc.、 Takeda Pharmaceutical Company Limited、 Regeneron Pharmaceuticals Inc.、 Ionis Pharmaceuticals Inc.、 Sarepta Therapeutics Inc.、 Ultragenyx Pharmaceutical Inc.、 Amicus Therapeutics Inc.、 Agios Pharmaceuticals Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、アルパース病治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のアルパース病治療市場：タイプ別、2018年-2023年、2024年-2029年
世界のアルパース病治療市場：タイプ別市場シェア、2022年
・言語療法、理学療法、その他

世界のアルパース病治療市場：用途別、2018年-2023年、2024年-2029年
世界のアルパース病治療市場：用途別市場シェア、2022年
・病院、研究所、その他

世界のアルパース病治療市場：地域・国別、2018年-2023年、2024年-2029年
世界のアルパース病治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるアルパース病治療のグローバル売上、2018年-2023年
・主要企業におけるアルパース病治療のグローバル売上シェア、2022年
・主要企業におけるアルパース病治療のグローバル販売量、2018年-2023年
・主要企業におけるアルパース病治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Roche Holdings AG、 Pfizer Inc.、 Novartis International AG、 Sanofi S.A.、 Merck & Co.Inc.、 Biogen Inc.、 Moderna Inc.、 Vertex Pharmaceuticals Incorporated、 Alexion Pharmaceuticals Inc.、 Takeda Pharmaceutical Company Limited、 Regeneron Pharmaceuticals Inc.、 Ionis Pharmaceuticals Inc.、 Sarepta Therapeutics Inc.、 Ultragenyx Pharmaceutical Inc.、 Amicus Therapeutics Inc.、 Agios Pharmaceuticals Inc.

*************************************************************

・調査・分析レポートの概要
アルパース病治療市場の定義
市場セグメント
世界のアルパース病治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアルパース病治療市場規模
世界のアルパース病治療市場規模：2022年 VS 2029年
世界のアルパース病治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアルパース病治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のアルパース病治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：言語療法、理学療法、その他
アルパース病治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、研究所、その他
アルパース病治療の用途別グローバル売上・予測

・地域別市場分析
地域別アルパース病治療市場規模 2022年と2029年
地域別アルパース病治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche Holdings AG、 Pfizer Inc.、 Novartis International AG、 Sanofi S.A.、 Merck & Co.Inc.、 Biogen Inc.、 Moderna Inc.、 Vertex Pharmaceuticals Incorporated、 Alexion Pharmaceuticals Inc.、 Takeda Pharmaceutical Company Limited、 Regeneron Pharmaceuticals Inc.、 Ionis Pharmaceuticals Inc.、 Sarepta Therapeutics Inc.、 Ultragenyx Pharmaceutical Inc.、 Amicus Therapeutics Inc.、 Agios Pharmaceuticals Inc.
...

This research report provides a comprehensive analysis of the Alpers Disease Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Alpers Disease Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Alpers Disease Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Alpers Disease Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Alpers Disease Treatment market presents opportunities for various stakeholders, including Hospital, Research Institute. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Alpers Disease Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global Alpers Disease Treatment market was valued at US$ 1320.5 million in 2022 and is projected to reach US$ 1886.2 million by 2029, at a CAGR of 5.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Alpers Disease Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Alpers Disease Treatment market.
Market Overview: The report provides a comprehensive overview of the Alpers Disease Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Speech Therapy, Physical Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Alpers Disease Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Alpers Disease Treatment market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Alpers Disease Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Alpers Disease Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Alpers Disease Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Alpers Disease Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Alpers Disease Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Alpers Disease Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Alpers Disease Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Speech Therapy
Physical Therapy
Others
Market segment by Application
Hospital
Research Institute
Others
Global Alpers Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Roche Holdings AG
Pfizer Inc.
Novartis International AG
Sanofi S.A.
Merck & Co.Inc.
Biogen Inc.
Moderna Inc.
Vertex Pharmaceuticals Incorporated
Alexion Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Sarepta Therapeutics Inc.
Ultragenyx Pharmaceutical Inc.
Amicus Therapeutics Inc.
Agios Pharmaceuticals Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alpers Disease Treatment, market overview.
Chapter 2: Global Alpers Disease Treatment market size in revenue.
Chapter 3: Detailed analysis of Alpers Disease Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alpers Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Alpers Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alpers Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alpers Disease Treatment Overall Market Size
2.1 Global Alpers Disease Treatment Market Size: 2022 VS 2029
2.2 Global Alpers Disease Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alpers Disease Treatment Players in Global Market
3.2 Top Global Alpers Disease Treatment Companies Ranked by Revenue
3.3 Global Alpers Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Alpers Disease Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Alpers Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alpers Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Alpers Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Alpers Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Alpers Disease Treatment Market Size Markets, 2022 & 2029
4.1.2 Speech Therapy
4.1.3 Physical Therapy
4.1.4 Others
4.2 By Type – Global Alpers Disease Treatment Revenue & Forecasts
4.2.1 By Type – Global Alpers Disease Treatment Revenue, 2018-2023
4.2.2 By Type – Global Alpers Disease Treatment Revenue, 2024-2029
4.2.3 By Type – Global Alpers Disease Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Alpers Disease Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research Institute
5.1.4 Others
5.2 By Application – Global Alpers Disease Treatment Revenue & Forecasts
5.2.1 By Application – Global Alpers Disease Treatment Revenue, 2018-2023
5.2.2 By Application – Global Alpers Disease Treatment Revenue, 2024-2029
5.2.3 By Application – Global Alpers Disease Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Alpers Disease Treatment Market Size, 2022 & 2029
6.2 By Region – Global Alpers Disease Treatment Revenue & Forecasts
6.2.1 By Region – Global Alpers Disease Treatment Revenue, 2018-2023
6.2.2 By Region – Global Alpers Disease Treatment Revenue, 2024-2029
6.2.3 By Region – Global Alpers Disease Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Alpers Disease Treatment Revenue, 2018-2029
6.3.2 US Alpers Disease Treatment Market Size, 2018-2029
6.3.3 Canada Alpers Disease Treatment Market Size, 2018-2029
6.3.4 Mexico Alpers Disease Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Alpers Disease Treatment Revenue, 2018-2029
6.4.2 Germany Alpers Disease Treatment Market Size, 2018-2029
6.4.3 France Alpers Disease Treatment Market Size, 2018-2029
6.4.4 U.K. Alpers Disease Treatment Market Size, 2018-2029
6.4.5 Italy Alpers Disease Treatment Market Size, 2018-2029
6.4.6 Russia Alpers Disease Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Alpers Disease Treatment Market Size, 2018-2029
6.4.8 Benelux Alpers Disease Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Alpers Disease Treatment Revenue, 2018-2029
6.5.2 China Alpers Disease Treatment Market Size, 2018-2029
6.5.3 Japan Alpers Disease Treatment Market Size, 2018-2029
6.5.4 South Korea Alpers Disease Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Alpers Disease Treatment Market Size, 2018-2029
6.5.6 India Alpers Disease Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Alpers Disease Treatment Revenue, 2018-2029
6.6.2 Brazil Alpers Disease Treatment Market Size, 2018-2029
6.6.3 Argentina Alpers Disease Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Alpers Disease Treatment Revenue, 2018-2029
6.7.2 Turkey Alpers Disease Treatment Market Size, 2018-2029
6.7.3 Israel Alpers Disease Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Alpers Disease Treatment Market Size, 2018-2029
6.7.5 UAE Alpers Disease Treatment Market Size, 2018-2029
7 Alpers Disease Treatment Companies Profiles
7.1 Roche Holdings AG
7.1.1 Roche Holdings AG Company Summary
7.1.2 Roche Holdings AG Business Overview
7.1.3 Roche Holdings AG Alpers Disease Treatment Major Product Offerings
7.1.4 Roche Holdings AG Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.1.5 Roche Holdings AG Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Alpers Disease Treatment Major Product Offerings
7.2.4 Pfizer Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Novartis International AG
7.3.1 Novartis International AG Company Summary
7.3.2 Novartis International AG Business Overview
7.3.3 Novartis International AG Alpers Disease Treatment Major Product Offerings
7.3.4 Novartis International AG Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.3.5 Novartis International AG Key News & Latest Developments
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Company Summary
7.4.2 Sanofi S.A. Business Overview
7.4.3 Sanofi S.A. Alpers Disease Treatment Major Product Offerings
7.4.4 Sanofi S.A. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.4.5 Sanofi S.A. Key News & Latest Developments
7.5 Merck & Co.Inc.
7.5.1 Merck & Co.Inc. Company Summary
7.5.2 Merck & Co.Inc. Business Overview
7.5.3 Merck & Co.Inc. Alpers Disease Treatment Major Product Offerings
7.5.4 Merck & Co.Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.5.5 Merck & Co.Inc. Key News & Latest Developments
7.6 Biogen Inc.
7.6.1 Biogen Inc. Company Summary
7.6.2 Biogen Inc. Business Overview
7.6.3 Biogen Inc. Alpers Disease Treatment Major Product Offerings
7.6.4 Biogen Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.6.5 Biogen Inc. Key News & Latest Developments
7.7 Moderna Inc.
7.7.1 Moderna Inc. Company Summary
7.7.2 Moderna Inc. Business Overview
7.7.3 Moderna Inc. Alpers Disease Treatment Major Product Offerings
7.7.4 Moderna Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.7.5 Moderna Inc. Key News & Latest Developments
7.8 Vertex Pharmaceuticals Incorporated
7.8.1 Vertex Pharmaceuticals Incorporated Company Summary
7.8.2 Vertex Pharmaceuticals Incorporated Business Overview
7.8.3 Vertex Pharmaceuticals Incorporated Alpers Disease Treatment Major Product Offerings
7.8.4 Vertex Pharmaceuticals Incorporated Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.8.5 Vertex Pharmaceuticals Incorporated Key News & Latest Developments
7.9 Alexion Pharmaceuticals Inc.
7.9.1 Alexion Pharmaceuticals Inc. Company Summary
7.9.2 Alexion Pharmaceuticals Inc. Business Overview
7.9.3 Alexion Pharmaceuticals Inc. Alpers Disease Treatment Major Product Offerings
7.9.4 Alexion Pharmaceuticals Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.9.5 Alexion Pharmaceuticals Inc. Key News & Latest Developments
7.10 Takeda Pharmaceutical Company Limited
7.10.1 Takeda Pharmaceutical Company Limited Company Summary
7.10.2 Takeda Pharmaceutical Company Limited Business Overview
7.10.3 Takeda Pharmaceutical Company Limited Alpers Disease Treatment Major Product Offerings
7.10.4 Takeda Pharmaceutical Company Limited Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.11 Regeneron Pharmaceuticals Inc.
7.11.1 Regeneron Pharmaceuticals Inc. Company Summary
7.11.2 Regeneron Pharmaceuticals Inc. Business Overview
7.11.3 Regeneron Pharmaceuticals Inc. Alpers Disease Treatment Major Product Offerings
7.11.4 Regeneron Pharmaceuticals Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.11.5 Regeneron Pharmaceuticals Inc. Key News & Latest Developments
7.12 Ionis Pharmaceuticals Inc.
7.12.1 Ionis Pharmaceuticals Inc. Company Summary
7.12.2 Ionis Pharmaceuticals Inc. Business Overview
7.12.3 Ionis Pharmaceuticals Inc. Alpers Disease Treatment Major Product Offerings
7.12.4 Ionis Pharmaceuticals Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.12.5 Ionis Pharmaceuticals Inc. Key News & Latest Developments
7.13 Sarepta Therapeutics Inc.
7.13.1 Sarepta Therapeutics Inc. Company Summary
7.13.2 Sarepta Therapeutics Inc. Business Overview
7.13.3 Sarepta Therapeutics Inc. Alpers Disease Treatment Major Product Offerings
7.13.4 Sarepta Therapeutics Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.13.5 Sarepta Therapeutics Inc. Key News & Latest Developments
7.14 Ultragenyx Pharmaceutical Inc.
7.14.1 Ultragenyx Pharmaceutical Inc. Company Summary
7.14.2 Ultragenyx Pharmaceutical Inc. Business Overview
7.14.3 Ultragenyx Pharmaceutical Inc. Alpers Disease Treatment Major Product Offerings
7.14.4 Ultragenyx Pharmaceutical Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.14.5 Ultragenyx Pharmaceutical Inc. Key News & Latest Developments
7.15 Amicus Therapeutics Inc.
7.15.1 Amicus Therapeutics Inc. Company Summary
7.15.2 Amicus Therapeutics Inc. Business Overview
7.15.3 Amicus Therapeutics Inc. Alpers Disease Treatment Major Product Offerings
7.15.4 Amicus Therapeutics Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.15.5 Amicus Therapeutics Inc. Key News & Latest Developments
7.16 Agios Pharmaceuticals Inc.
7.16.1 Agios Pharmaceuticals Inc. Company Summary
7.16.2 Agios Pharmaceuticals Inc. Business Overview
7.16.3 Agios Pharmaceuticals Inc. Alpers Disease Treatment Major Product Offerings
7.16.4 Agios Pharmaceuticals Inc. Alpers Disease Treatment Revenue in Global Market (2018-2023)
7.16.5 Agios Pharmaceuticals Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Alpers Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Alpers Disease Treatment Market Drivers in Global Market
Table 3. Alpers Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Alpers Disease Treatment in Global Market
Table 5. Top Alpers Disease Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Alpers Disease Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Alpers Disease Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Alpers Disease Treatment Product Type
Table 9. List of Global Tier 1 Alpers Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpers Disease Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Alpers Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Alpers Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Alpers Disease Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Alpers Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Alpers Disease Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Alpers Disease Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Alpers Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Alpers Disease Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Alpers Disease Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Alpers Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Alpers Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Alpers Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Alpers Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Alpers Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Alpers Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Alpers Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Alpers Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Alpers Disease Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Alpers Disease Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Roche Holdings AG Company Summary
Table 31. Roche Holdings AG Alpers Disease Treatment Product Offerings
Table 32. Roche Holdings AG Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Holdings AG Key News & Latest Developments
Table 34. Pfizer Inc. Company Summary
Table 35. Pfizer Inc. Alpers Disease Treatment Product Offerings
Table 36. Pfizer Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Inc. Key News & Latest Developments
Table 38. Novartis International AG Company Summary
Table 39. Novartis International AG Alpers Disease Treatment Product Offerings
Table 40. Novartis International AG Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis International AG Key News & Latest Developments
Table 42. Sanofi S.A. Company Summary
Table 43. Sanofi S.A. Alpers Disease Treatment Product Offerings
Table 44. Sanofi S.A. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi S.A. Key News & Latest Developments
Table 46. Merck & Co.Inc. Company Summary
Table 47. Merck & Co.Inc. Alpers Disease Treatment Product Offerings
Table 48. Merck & Co.Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Merck & Co.Inc. Key News & Latest Developments
Table 50. Biogen Inc. Company Summary
Table 51. Biogen Inc. Alpers Disease Treatment Product Offerings
Table 52. Biogen Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Biogen Inc. Key News & Latest Developments
Table 54. Moderna Inc. Company Summary
Table 55. Moderna Inc. Alpers Disease Treatment Product Offerings
Table 56. Moderna Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Moderna Inc. Key News & Latest Developments
Table 58. Vertex Pharmaceuticals Incorporated Company Summary
Table 59. Vertex Pharmaceuticals Incorporated Alpers Disease Treatment Product Offerings
Table 60. Vertex Pharmaceuticals Incorporated Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Vertex Pharmaceuticals Incorporated Key News & Latest Developments
Table 62. Alexion Pharmaceuticals Inc. Company Summary
Table 63. Alexion Pharmaceuticals Inc. Alpers Disease Treatment Product Offerings
Table 64. Alexion Pharmaceuticals Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Alexion Pharmaceuticals Inc. Key News & Latest Developments
Table 66. Takeda Pharmaceutical Company Limited Company Summary
Table 67. Takeda Pharmaceutical Company Limited Alpers Disease Treatment Product Offerings
Table 68. Takeda Pharmaceutical Company Limited Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 70. Regeneron Pharmaceuticals Inc. Company Summary
Table 71. Regeneron Pharmaceuticals Inc. Alpers Disease Treatment Product Offerings
Table 72. Regeneron Pharmaceuticals Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Regeneron Pharmaceuticals Inc. Key News & Latest Developments
Table 74. Ionis Pharmaceuticals Inc. Company Summary
Table 75. Ionis Pharmaceuticals Inc. Alpers Disease Treatment Product Offerings
Table 76. Ionis Pharmaceuticals Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Ionis Pharmaceuticals Inc. Key News & Latest Developments
Table 78. Sarepta Therapeutics Inc. Company Summary
Table 79. Sarepta Therapeutics Inc. Alpers Disease Treatment Product Offerings
Table 80. Sarepta Therapeutics Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Sarepta Therapeutics Inc. Key News & Latest Developments
Table 82. Ultragenyx Pharmaceutical Inc. Company Summary
Table 83. Ultragenyx Pharmaceutical Inc. Alpers Disease Treatment Product Offerings
Table 84. Ultragenyx Pharmaceutical Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Ultragenyx Pharmaceutical Inc. Key News & Latest Developments
Table 86. Amicus Therapeutics Inc. Company Summary
Table 87. Amicus Therapeutics Inc. Alpers Disease Treatment Product Offerings
Table 88. Amicus Therapeutics Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 89. Amicus Therapeutics Inc. Key News & Latest Developments
Table 90. Agios Pharmaceuticals Inc. Company Summary
Table 91. Agios Pharmaceuticals Inc. Alpers Disease Treatment Product Offerings
Table 92. Agios Pharmaceuticals Inc. Alpers Disease Treatment Revenue (US$, Mn) & (2018-2023)
Table 93. Agios Pharmaceuticals Inc. Key News & Latest Developments
List of Figures
Figure 1. Alpers Disease Treatment Segment by Type in 2022
Figure 2. Alpers Disease Treatment Segment by Application in 2022
Figure 3. Global Alpers Disease Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Alpers Disease Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Alpers Disease Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alpers Disease Treatment Revenue in 2022
Figure 8. By Type - Global Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Alpers Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Alpers Disease Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 16. US Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 28. China Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Alpers Disease Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Alpers Disease Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Holdings AG Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis International AG Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi S.A. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck & Co.Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biogen Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Moderna Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Vertex Pharmaceuticals Incorporated Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Alexion Pharmaceuticals Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Pharmaceutical Company Limited Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Regeneron Pharmaceuticals Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Ionis Pharmaceuticals Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sarepta Therapeutics Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Ultragenyx Pharmaceutical Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Amicus Therapeutics Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Agios Pharmaceuticals Inc. Alpers Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 慢性閉塞性肺疾患治療薬のグローバル市場展望 2023年-2029年：気管支拡張薬、PDE-4阻害薬、ステロイド、その他
  • ドライアイ疾患用治療装置のグローバル市場展望 2023年-2029年：マイボーム腺詰まり解消器具、涙点閉塞、鎮痛器具、その他
  • ドライアイ治療薬のグローバル市場展望 2023年-2029年：人工涙液、抗炎症薬、その他
  • 好酸球性喘息治療薬のグローバル市場展望 2023年-2029年：点滴静注型、皮下注射型
  • 各種肝硬変治療サービスのグローバル市場展望 2023年-2029年：手術治療、内科治療
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12239 )"アルパース病治療のグローバル市場展望 2023年-2029年：言語療法、理学療法、その他" (英文：Alpers Disease Treatment Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。